Skip to content

Media Release: July 1, 2010


Increase Above the President’s Request Welcomed; FDA Still Underfunded for Its Responsibilities

WASHINGTON, D.C., July 1, 2010 – The Alliance for a Stronger FDA today applauded increases for FDA included in the House Agriculture/FDA Appropriations subcommittee mark-up held yesterday afternoon. The subcommittee mark for FDA is for $2.571 billion, an increase of $214 million above FY 10 and $55 million above the President’s request.

“The Alliance is very pleased with this proposed increase. It demonstrates that Members of Congress recognize that FDA needs to be an exception to efforts to cut the federal budget,” said Wayne Pines, President of the Alliance. “We applaud the leadership of Chairwoman De Lauro, Ranking Member Kingston and the members of the subcommittee.”

The President’s budget request was for an increase of nearly 6 1/2 % over FY 10. At the time of the budget’s release in February, the Alliance expressed gratitude that they agency would receive an inflationary increase in a year in which most domestic discretionary programs are likely to be frozen or cut. The House subcommittee mark is an improvement over the President’s request and totals 9% above the FY 10 expenditure levels.

“The Alliance will continue to advocate for further increases in funding above the House subcommittee level,” continued Mr. Pines. “The American people must rely on FDA to assure the safety of products that constitute more than 20 cents of every consumer dollar spent.  Continuing chronic underfunding of FDA affects our public health, our economy and our national security.”

“Despite funding increases over the last 3 years, Congress and the American public should realize that FDA’s FY 10 appropriation supported the same number of full-time employees as 16 years ago, a time in which FDA faced fewer and less complex domestic and international challenges,” said Nancy Bradish Myers, Vice President of the Alliance and President of Catalyst Healthcare Consulting. “It would be short-sighted to leave our premier public health agency overextended and ill-equipped to carry out its mission.”

Chairwoman DeLauro’s statement is at:

The summary table showing how different agencies (including FDA) fared is at:

The Alliance for a Stronger FDA is a coalition of more than 180 consumer, patient, professional and research groups, companies, trade associations, and individuals who support increased appropriated funding for FDA.  The Alliance is the only multi-stakeholder group that advocates for increasing resources at FDA to match the agency’s responsibilities. More information about the Alliance can be found at